With a cannabis connection, this stock has the potential to be a major player in the biotech industry.

The what is the best biotech stock to buy right now is a question that has been asked many times. There are many companies in this space, but one company that stands out from the rest is GW Pharmaceuticals plc (GWPH).

Heres-an-Up-and-Coming-Biotech-Stock-to-Watch-With-a-Cannabis

 

There aren’t many biotech companies working on the development of cannabis right now. Ginkgo Bioworks (NYSE:DNA) is one of them, having just gone public after a combination with a special purpose acquisition firm. Keith Speights and Brian Orelli, Motley Fool contributors, address a viewer’s question regarding this biotech with a cannabis link in this Motley Fool Live video from September 22, 2021.

 

 

This Month’s Best Stocks to Buy

Iain Butler, a well-known Canadian investor, has released a list of ten companies that Canadians should buy RIGHT NOW. So, if you’re bored of reading about other people making money in the stock market, this might be your lucky day.

Keith Speights (Keith): Grant inquires, “What are your DNA knowledge levels? It’s a great ticker, and I’m amazed it’s still accessible.”

Orelli, Brian: Yeah. This was the Genentech ticker from back in the day. The ticker was DNA at Genentech, and it was purchased twice by Roche. But, in the end, Roche bought it outright and took it over. It was bought by Roche, spun off, and then bought back by Roche. Because no one took control after Roche, the ticker DNA was still accessible. This is Ginkgo Bio, which is a technology that I can’t recall the rest of.

Speights: I believe it’s BioWorks.

Orelli: BioWorks, for sure. I knew it was related to biotechnology, but I couldn’t think of it. This is a synthetic biotechnology firm. The greatest concern I have with synthetic biotech is that you have to understand both how they create the medicine and how they make the product, which is frequently not a medication. However, you must also comprehend their potential for the goods that they produce.

That, I believe, is the true challenge with synthetic biotech companies: you have to grasp both the science and the potential for their goods, which may or may not be linked to biotechs.

I believe we saw one that failed earlier this year, and it was creating a covering for foldable phone displays. If you don’t grasp the market for foldable sweet screens, you won’t be able to fully appreciate the company’s potential.

Ginkgo has its toes in the cannabis water as well, for those of you who follow the cannabis sector. I believe it is collaborating with Cronos Group (NASDAQ:CRON), a Canadian cannabis grower, to create cannabinoids via fermentation. Interesting stock that combines healthcare and cannabis. As Grant said, they were able to get a fantastic ticker to utilize.

  • biotech stocks under $5
  • biotech stocks that could explode
  • biotech penny stocks
  • biotech stock symbol
  • anti aging stocks 2021
You May Also Like

Nearly $3 million worth of cannabis found in boxes of chili peppers

While many eat chili peppers because they are tasty, they are also…

An interview with Alaskan Made Online Cannabis Wholesale Service

Alaskan Made Online is a wholesale cannabis service that takes the hassle…

MARIJUANA STOCKS TO INVEST IN 2020 (NYSE: APHA), (NASDAQOTH: TCNNF), (NASDAQOTH: KSHB), (NASDAQOTH: LHSIF), (NASDAQOTH: ORHOF), (NASDAQOTH: SPRWF)

As the marijuana industry continues to grow into a major global market,…